OpportunityTitle: Replication of Key Clinical Trials Initiative (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:   Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.    Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Description: In response to the significant need to replicate influential behavioral and pharmacological clinical trials of therapeutic approaches to the treatment of Alcohol Use Disorders and alcoholic liver disease, this Funding Opportunity Announcement (FOA) invites applications for a limited number of Cooperative Agreements (U01) for the purpose of conducting replication studies of key single-site proof of concept clinical trials of a behavioral or pharmacologic nature.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster &lt;br/&gt;FBOWebmaster@OD.NIH.GOV &lt;br/&gt;